ZA200500744B - Minimally compliant, volume efficient piston for osmotic drug delivery systems - Google Patents

Minimally compliant, volume efficient piston for osmotic drug delivery systems

Info

Publication number
ZA200500744B
ZA200500744B ZA200500744A ZA200500744A ZA200500744B ZA 200500744 B ZA200500744 B ZA 200500744B ZA 200500744 A ZA200500744 A ZA 200500744A ZA 200500744 A ZA200500744 A ZA 200500744A ZA 200500744 B ZA200500744 B ZA 200500744B
Authority
ZA
South Africa
Prior art keywords
capsule
piston
agent
osmotic
drug delivery
Prior art date
Application number
ZA200500744A
Other languages
English (en)
Inventor
Scott D Lautenbach
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA200500744B publication Critical patent/ZA200500744B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M2005/14513—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons with secondary fluid driving or regulating the infusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200500744A 2002-06-26 2006-01-25 Minimally compliant, volume efficient piston for osmotic drug delivery systems ZA200500744B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39200402P 2002-06-26 2002-06-26

Publications (1)

Publication Number Publication Date
ZA200500744B true ZA200500744B (en) 2006-03-29

Family

ID=30000792

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200500744A ZA200500744B (en) 2002-06-26 2006-01-25 Minimally compliant, volume efficient piston for osmotic drug delivery systems

Country Status (20)

Country Link
US (3) US6939556B2 (fi)
EP (1) EP1551493B1 (fi)
JP (1) JP4485945B2 (fi)
KR (1) KR101046903B1 (fi)
CN (1) CN100453130C (fi)
AT (1) ATE376854T1 (fi)
AU (1) AU2003256308B2 (fi)
BR (1) BR0312429A (fi)
CA (1) CA2490544C (fi)
DE (1) DE60317225T2 (fi)
EC (1) ECSP055578A (fi)
ES (1) ES2295642T3 (fi)
HK (1) HK1080402A1 (fi)
IL (1) IL165975A (fi)
MX (1) MXPA05000224A (fi)
NO (1) NO20050368L (fi)
NZ (1) NZ537628A (fi)
TW (1) TW200531709A (fi)
WO (1) WO2004002565A1 (fi)
ZA (1) ZA200500744B (fi)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
MXPA05006604A (es) * 2002-12-19 2006-05-25 Alza Corp Geles de una sola fase, no acuosos, estables, y formulaciones de los mismos para el suministro desde un aparato implantable.
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US20050010196A1 (en) * 2003-03-31 2005-01-13 Fereira Pamela J. Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
CA2520610A1 (en) * 2003-03-31 2004-10-21 Alza Corporation Osmotic pump with means for dissipating internal pressure
BRPI0416177A (pt) * 2003-11-06 2007-01-09 Alza Corp redutor de taxa de embebição modular para uso com bomba osmótica implantável
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
EP1827385B1 (en) 2004-11-23 2013-03-27 Adamas Pharmaceuticals, Inc. Pharmaceutical composition comprising memantine in an extended dosage release form for use in the treatment of dementias
CA2588296A1 (en) 2004-11-24 2006-06-01 Neuromolecular Pharmaceuticals, Inc. Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
EP2361630A1 (en) * 2005-02-03 2011-08-31 Intarcia Therapeutics, Inc Implantable drug delivery device comprising particles and an osmotic pump
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US7959938B2 (en) * 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
EP2243475B1 (en) 2005-04-06 2016-01-13 Adamas Pharmaceuticals, Inc. Combination of memantine and donepezil for treatment of CNS disorders
EP1948183B1 (en) * 2005-10-13 2013-12-18 Duke University Compositions for the treatment and prevention of heart disease and methods of using same
ES2351527T3 (es) 2006-05-30 2011-02-07 Intarcia Therapeutics, Inc Modulador de flujo en dos piezas con conducto interno para un sistema osmótico de administración.
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
AU2008244523B2 (en) * 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
US8105261B2 (en) * 2007-07-02 2012-01-31 Cardiac Pacemakers, Inc. Osmotic devices and methods for diuretic therapy
US8394644B2 (en) 2007-11-08 2013-03-12 Honeywell International Inc. Microfluidic osmotic pump
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
MX2011003833A (es) * 2008-10-15 2011-06-20 Intarcia Therapeutics Inc Particulas de farmacos altamente concentradas, formulaciones, suspensiones y uso de las mismas.
CA2765734C (en) * 2009-06-26 2016-12-13 Taris Biomedical, Inc. Implantable drug delivery devices and methods of making the same
KR102093612B1 (ko) * 2009-09-28 2020-03-26 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
CA2776173A1 (en) 2009-09-30 2011-04-07 Nicholas Marini Cofactors and methods of use for individuals
US8741343B2 (en) 2009-12-02 2014-06-03 Adamas Pharmaceuticals, Inc. Method of administering amantadine prior to a sleep period
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
EP3466418A1 (en) 2011-07-15 2019-04-10 NuSirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
KR101723319B1 (ko) * 2012-10-12 2017-04-04 일라이 릴리 앤드 캄파니 화학 엔진, 및 특히 고점성 유체의 주사에서의 그의 사용을 위한 방법
WO2014078459A1 (en) 2012-11-13 2014-05-22 Nusirt Sciences, Inc. Compositions and methods for increasing energy metabolism
EP2945616B1 (en) 2013-01-15 2018-11-28 NuSirt Sciences, Inc. Treating pulmonary conditions
EP2964310A1 (en) * 2013-03-05 2016-01-13 TARIS Biomedical LLC Drug delivery devices and methods for controlled drug release through device orifice
MX2015011195A (es) 2013-03-15 2016-03-11 Nusirt Sciences Inc La leucina y el acido nicotinico reducen los niveles de lipidos.
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine
RU2016138136A (ru) 2014-02-27 2018-04-02 Нусерт Сайенсиз, Инк. Композиции и способы уменьшения или профилактики жировой дистрофии печени
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR20240042548A (ko) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
SG11201803353PA (en) 2015-11-05 2018-05-30 Massachusetts Gen Hospital Intrathecal delivery of nucleic acid sequences encoding abcd1 for treatment of adrenomyeloneuropathy
US10973783B2 (en) 2015-12-30 2021-04-13 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of seizure-related disorders
TWI814219B (zh) 2016-05-16 2023-09-01 美商因塔希亞治療公司 升糖素受體選擇性多肽和彼之使用方法
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
US10406336B2 (en) 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
WO2018075901A1 (en) 2016-10-20 2018-04-26 Peptron, Inc. Methods of delivering a neuroprotective polypeptide to the central nervous system
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
WO2018152018A1 (en) 2017-02-17 2018-08-23 Eli Lilly And Company Processes and devices for delivery of fluid by chemical reaction
AU2018231249A1 (en) 2017-03-08 2019-09-26 Intarcia Therapeutics, Inc Apparatus and methods for administration of a nauseogenic compound from a drug delivery device
WO2018200885A1 (en) 2017-04-26 2018-11-01 Neurocentria, Inc. Magnesium compositions and methods of use
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
WO2020041774A1 (en) * 2018-08-23 2020-02-27 Baywind Bioventures Capsule device for delivery of active agent to gastrointestinal tract
BR112021006823A2 (pt) 2018-10-11 2021-07-27 Intarcia Therapeutics, Inc. polipeptídeos análogos de amilina humana e métodos de uso

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753651A (en) 1982-08-30 1988-06-28 Alza Corporation Self-driven pump
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4558888A (en) * 1983-09-19 1985-12-17 Minnesota Mining And Manufacturing Company Strip of binding tape
US4874388A (en) 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5728088A (en) * 1988-12-13 1998-03-17 Alza Corporation Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US5234424A (en) * 1988-12-28 1993-08-10 Alza Corporation Osmotically driven syringe
US4969884A (en) 1988-12-28 1990-11-13 Alza Corporation Osmotically driven syringe
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5030216A (en) * 1989-12-15 1991-07-09 Alza Corporation Osmotically driven syringe
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5234692A (en) * 1990-07-11 1993-08-10 Alza Corporation Delivery device with a protective sleeve
US5180591A (en) 1990-07-11 1993-01-19 Alza Corporation Delivery device with a protective sleeve
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5861166A (en) * 1991-03-12 1999-01-19 Alza Corporation Delivery device providing beneficial agent stability
CN2085662U (zh) * 1991-03-29 1991-10-02 毕勇 药物″渗透泵″的生产装置
US5137727A (en) 1991-06-12 1992-08-11 Alza Corporation Delivery device providing beneficial agent stability
WO1993006821A1 (en) 1991-10-04 1993-04-15 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release tablet
ZA927779B (en) * 1991-10-10 1993-07-05 Alza Corp Osmotic drug delivery devices with hydrophobic wall materials.
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5456679A (en) * 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5209746A (en) 1992-02-18 1993-05-11 Alza Corporation Osmotically driven delivery devices with pulsatile effect
US5308348A (en) * 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
US5221278A (en) 1992-03-12 1993-06-22 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
US5540665A (en) * 1994-01-31 1996-07-30 Alza Corporation Gas driven dispensing device and gas generating engine therefor
US5458888A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
US5690952A (en) * 1995-06-07 1997-11-25 Judy A. Magruder et al. Implantable system for delivery of fluid-sensitive agents to animals
US6132420A (en) * 1996-02-02 2000-10-17 Alza Corporation Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
US6395292B2 (en) * 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
US6156331A (en) * 1996-02-02 2000-12-05 Alza Corporation Sustained delivery of an active agent using an implantable system
DE69731902T2 (de) * 1996-02-02 2005-12-22 Alza Corp., Mountain View Implantierbares System mit verzögerter Wirkstofffreisetzung
US6261584B1 (en) * 1996-02-02 2001-07-17 Alza Corporation Sustained delivery of an active agent using an implantable system
ZA981610B (en) * 1997-03-24 1999-08-26 Alza Corp Self adjustable exit port.
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
MY125849A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
JP4173635B2 (ja) 1997-12-29 2008-10-29 インターシア セラピューティクス，インコーポレイティド 膜プラグ保持機構を有する浸透供給装置
IL143691A0 (en) * 1998-12-17 2002-04-21 Alza Corp Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
KR20040007413A (ko) * 2000-11-03 2004-01-24 바이오메디신즈 인코포레이티드 단기 및 장기 약물 약량측정 방법

Also Published As

Publication number Publication date
EP1551493A1 (en) 2005-07-13
DE60317225D1 (de) 2007-12-13
HK1080402A1 (en) 2006-04-28
US20070088337A1 (en) 2007-04-19
WO2004002565A1 (en) 2004-01-08
ECSP055578A (es) 2005-04-18
JP4485945B2 (ja) 2010-06-23
KR101046903B1 (ko) 2011-07-06
AU2003256308B2 (en) 2008-07-03
MXPA05000224A (es) 2005-06-03
CN1671439A (zh) 2005-09-21
US20060111693A1 (en) 2006-05-25
US6939556B2 (en) 2005-09-06
CN100453130C (zh) 2009-01-21
KR20050026416A (ko) 2005-03-15
NO20050368L (no) 2005-01-24
EP1551493B1 (en) 2007-10-31
IL165975A0 (en) 2006-01-15
US20040019345A1 (en) 2004-01-29
IL165975A (en) 2009-07-20
BR0312429A (pt) 2005-04-19
US7112335B2 (en) 2006-09-26
ES2295642T3 (es) 2008-04-16
DE60317225T2 (de) 2008-05-29
JP2005530588A (ja) 2005-10-13
CA2490544C (en) 2011-04-19
ATE376854T1 (de) 2007-11-15
NZ537628A (en) 2005-12-23
CA2490544A1 (en) 2004-01-08
TW200531709A (en) 2005-10-01
AU2003256308A1 (en) 2004-01-19

Similar Documents

Publication Publication Date Title
HK1080402A1 (en) Minimally compliant, volume efficient piston for osmotic drug delivery systems
WO2000040218A3 (en) Osmotic delivery system having space efficient piston
BRPI0407366A (pt) Envoltório com liberação de pressão por ação de came
CA2402637A1 (en) Valve for osmotic devices
EP1610000A3 (en) A gas compression system
EP2386325A3 (en) Needle-free injection system
ZA9610374B (en) Cartridge-based drug delivery device
AU2003218458A1 (en) Valved intradermal delivery device
MX2009008519A (es) Barril/embolo interior hueco de jeringa en jeringa con sello y membrana rompible integrales y equipos, sistemas y metodos relacionados.
AU2003217111A1 (en) Fluid transfer assembly
HUP0302377A2 (hu) Fecskendő, nyomáskamra és eljárás folyékony gyógyszer injekciózására
AU2001295350A1 (en) Implantable medical device for delivering a liquid
WO2003026557A3 (en) Method and device for the iontophoretic delivery of a drug
WO2002068013A3 (en) Multiple canopy
CA2489325A1 (en) Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
EP2446911A3 (en) Self-contained portable apparatus for administration of a drug solution
WO2003009884A3 (en) Elongated syringe
NZ544741A (en) Device for the dosed delivery of a fluid, such as an infuser, using CO2 produced from the mixing of an base and an acid
EP1633426A4 (en) PROVISION OF THERAPEUTIC AGENT
WO1998057695A8 (en) Drug delivery system
GB0212047D0 (en) Generation of therapeutic microfoam
CA2492836A1 (en) Administration device comprising an osmotic drive
WO2004041068A3 (en) Guided capsule for wireless endoscopy, biopsy, and drug delivery
GB0102386D0 (en) Method for filling needless injector capsules
AU2003250952A1 (en) Use of a disposable container, microfluidic device and method for processing molecules